Price movement over the last 24 hours
ARK Genomic Revolution ETF vs KraneShares CSI China Internet ETF — how do they compare? ARK Genomic Revolution ETF trades at $41, while KraneShares CSI China Internet ETF trades at $26.26. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | KWEB | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $42.94 |
52-Week Low | $23.09 | $23.63 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
KWEB trades at $26.38, down 0.38% on the day, with technical indicators showing mixed signals - bullish moving averages but neutral oscillators. The ETF offers concentrated exposure to Chinese internet and AI companies, currently trading near 52-week lows according to Seeking Alpha analysis from June 29, 2026. Recent news highlights China's significant AI infrastructure investments and strong export performance, providing potential catalysts for the underlying holdings.
The ETF presents a value opportunity with Chinese tech stocks trading at discounts to Western peers, though geopolitical tensions and regulatory risks remain concerns. AI-driven growth and government support for technology sectors offer upside potential, but investors face China-specific market volatility and US-China trade friction risks that could impact performance.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →